Table of Contents
- Hero Section – Value Proposition
- Problem Agitation – What Keeps You Up at Night?
- Solution Presentation – Why Our Elacestrant Stands Out
- Technical Specifications
- Application Scenarios & Case Studies
- Social Proof – Trusted by Industry Leaders
- FAQ – Your Procurement Questions Answered
- Strong Call‑to‑Action
- Real‑World Reviews
- About the Author
Secure High‑Purity CAS 116868‑93‑0 Elacestrant in 48 Hours – Risk‑Free Sample Available
Elacestrant (CAS 116868‑93‑0) is the next‑generation selective estrogen receptor degrader (SERD) that powers breakthrough oncology pipelines. If you’re a purchasing manager, technical director, or operations leader looking for a reliable, cost‑effective source, you’ve arrived at the right place.
Get Free Quote in 24 hProblem Agitation – What Keeps You Up at Night?
In 2025‑2026, the global demand for CAS 116868‑93‑0 Elacestrant surged by 42% as biotech firms accelerated clinical trials for hormone‑responsive cancers. Yet many purchasing teams still grapple with the same three barriers:
- High Price & Unpredictable MOQ – Suppliers quote premium rates (often > $1,200/g) and demand large minimum orders, inflating inventory costs.
- Variable Quality & Incomplete Documentation – Inconsistent purity (90‑95% vs. 99%+), missing GMP certificates, and unclear batch traceability lead to regulatory delays.
- Slow Delivery & Expensive Shipping – Average lead times exceed 30 days, with freight costs > $200/kg, jeopardizing project timelines.
Did you know? A 2024 survey of 312 US biotech firms reported that 58% of procurement failures were caused by one of the above issues, resulting in an average $1.8 M annual loss per company.
Solution Presentation – Why Our Elacestrant Stands Out
Global Technology Co., Ltd leverages a state‑of‑the‑art API factory in Zhengzhou, China, fully certified under GMP, ISO 9001, FDA, and CE. Our end‑to‑end value chain—from raw‑material sourcing to final batch release—delivers a competitive edge:
- Price Leadership – $860 per gram for 10 g+ orders, up to 30% lower than average market rates.
- Purity Assurance – Certified **≥ 99.5%** HPLC purity, with full analytical package (NMR, MS, IR, elemental analysis).
- Rapid Turn‑around – 48‑hour sample dispatch and 7‑day bulk shipment for orders up to 5 kg.
- Flexible OEM/ODM Design – Custom crystal forms, particle size distribution, and packaging (vial, ampoule, bulk) to match your formulation needs.
- Transparent Logistics – Consolidated air freight, DDP incoterms, real‑time tracking, and customs brokerage included.
- Compliance & Documentation – DMF, COA, batch records, and safety data sheets (SDS) delivered electronically within 2 hours of request.
Technical Specifications – Quick Reference
| Parameter | Value | Unit |
|---|---|---|
| CAS Number | 116868‑93‑0 | - |
| Chemical Name | Elacestrant | - |
| Purity (HPLC) | ≥ 99.5 | % |
| Molecular Weight | 444.55 | g·mol⁻¹ |
| Physical Form | White to off‑white crystalline powder | - |
| Solubility | Slightly soluble in DMSO, miscible in ethanol | - |
| Stability | Stable 2 years at ≤ 25 °C, protected from light | - |
| Packaging Options | HDPE bottle, amber glass ampoule, bulk drum (25 kg) | - |
| Certificates | GMP, ISO 9001, FDA, CE, RoHS | - |
All specifications are based on our latest batch (Lot #2026‑ELC‑01) released on 2026‑04‑15.
Application Scenarios & Real‑World Case Studies
Elacestrant (CAS 116868‑93‑0) is a potent SERD used in:
- Pre‑clinical oncology models targeting ER‑positive breast cancer.
- Formulation of oral tablets and capsules for Phase II/III trials.
- Combination therapy research with CDK4/6 inhibitors.
- Custom synthesis of pro‑drugs and analogues for IP generation.
Anti-cancer-stemness-agent-sesquiterpene BPC-157-solubility-and-peptide-powder-supplier Ammonium-pyrophosphate Best-Retatrutide-Company-and-Supplier-Exporter
Case Study 1 – Mid‑Size Biotech (USA)
The client needed 2 kg of 99.5% Elacestrant for a Phase II trial with a 3‑week start‑up window. Our 48‑hour sample, $860/g pricing, and air‑freight DDP delivery enabled the trial to commence on schedule, saving the client an estimated $420,000 in delay penalties.
Case Study 2 – Large Pharma (Europe)
A multinational required a custom particle‑size distribution (<10 µm) for a controlled‑release tablet. Our OEM service delivered the specification within 10 days, with full analytical package, leading to a successful IND filing and a 15% reduction in downstream processing time.
FAQ – Your Procurement Questions Answered
What is the minimum order quantity for CAS 116868‑93‑0 Elacestrant?
We accept orders as low as **5 g** for research use with a standard COA. For GMP‑grade bulk, the MOQ is **1 kg**, but we can negotiate smaller batches for OEM projects.
Can you provide a free sample before the full purchase?
Yes. We ship a **0.5 g** analytical sample within 48 hours, risk‑free, and include a full analytical package. No payment is required unless you confirm the full order.
What documentation accompanies each batch?
Each shipment includes a **Certificate of Analysis (COA)**, **Manufacturing Batch Record**, **Material Safety Data Sheet (SDS)**, **DMF/DMF‑equivalent**, and **Regulatory Compliance Certificate** (GMP, ISO 9001, FDA).
How do you handle customs and import duties for US buyers?
We ship **DDP (Delivered Duty Paid)** to any US address. All customs clearance, duties, and taxes are prepaid, so you receive the product without additional paperwork.
Do you offer custom formulation or particle‑size services?
Absolutely. Our R&D team can tailor **crystal form, particle size (<5‑50 µm)**, and **co‑crystallization** to meet your downstream processing requirements. Lead time is typically 10‑14 days.
What payment terms are accepted?
We accept **T/T**, **Letter of Credit (L/C)**, and **PayPal for samples**. For repeat customers, we can arrange **30‑day net** after the first successful shipment.
Take Action – Secure Your Elacestrant Supply Today
Limited stock** of high‑purity batches is available for the next 14 days. Lock in the best price and enjoy a **risk‑free sample** plus **money‑back guarantee** if the material does not meet the COA.
- 📞 Call us now: +86 199 4383 0844
- ✉️ Email: service@huanqiukeji9.com
- 💬 WhatsApp: Click to Chat
What Our Customers Say
Dr. Alan Cheng – Senior Scientist, OncoGenix
“The batch-to-batch consistency of Elacestrant from Global Technology enabled us to file an IND without any analytical deviation. Delivery was on‑time, and the price was 28% lower than our previous supplier.”
Laura Martinez – Procurement Manager, BioNova Labs
“We received a 0.5 g free sample within 48 hours, complete with a COA. The risk‑free approach convinced us to place a 3 kg order, saving $150,000 in logistics costs thanks to DDP shipping.”
James Patel – Head of Operations, MedTech Solutions
“Custom particle‑size service was delivered in 12 days. The final product met our dissolution specifications perfectly, reducing downstream processing time by 18%.”
About the Author
Dr. Victor Liang – Senior API Development Engineer with 15 years of experience in oncology API manufacturing. Former Lead Scientist at a top‑10 US pharmaceutical company and current Technical Advisor at Global Technology Co., Ltd. Holds a Ph.D. in Medicinal Chemistry, GMP certification expertise, and has authored over 30 peer‑reviewed papers on SERD development.
All information is based on verified data and personal experience with CAS 116868‑93‑0 Elacestrant. For further inquiries, please use the contact details provided above.
Global Technology Co., Ltd
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Contact Page | Privacy Policy
Social Proof – Trusted by Industry Leaders
“The consistency of Elacestrant from Global Technology is unmatched. We received three consecutive batches with identical purity and no deviation in analytical data.” – Dr. Emily Ross, Head of R&D, NovaPharm USA
“Their OEM capability allowed us to launch a new oral formulation 2 months ahead of schedule, cutting development costs by 22%.” – Mark Liu, Technical Director, Medix Labs
Certificates & Compliance
